Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.5255
+0.0419 (8.66%)
Mar 9, 2026, 2:19 PM EDT - Market open
Longeveron Market Cap
Longeveron has a market cap or net worth of $11.21 million as of March 9, 2026. Its market cap has decreased by -53.93% in one year.
Market Cap
11.21M
Enterprise Value
2.06M
1-Year Change
-53.93%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $11.21M, a decrease of -93.50%. That is a compound annual growth rate of -41.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 10.32M | -4.43% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 12.12M |
| Soligenix | 11.99M |
| BiomX | 11.63M |
| Chemomab Therapeutics | 11.63M |
| CalciMedica | 11.49M |
| Akari Therapeutics, | 11.40M |
| Cellectar Biosciences | 11.24M |
| Liminatus Pharma | 10.81M |